| 196 |
183: Abnormal, Morphogenesis |
342: Increased, Lethality |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 197 |
183: Abnormal, Morphogenesis |
366: Increased, Structural malformations |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 168 |
158: N/A, Interferences with SH-/selen-proteins |
130: Depletion, GSH |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 199 |
350: Increase, Mortality |
361: Decline, Population |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 200 |
351: Increased Mortality |
361: Decline, Population |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 202 |
185: Increase, Mutations |
336: Increase, Heritable mutations in offspring |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 203 |
186: Altered, Neuroanatomy |
192: Altered, Neurophysiology |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 207 |
352: N/A, Neurodegeneration |
188: Neuroinflammation |
Nov 29, 2016 |
Jun 13, 2018 |
2 AOPs
|
| 208 |
188: Neuroinflammation |
352: N/A, Neurodegeneration |
Nov 29, 2016 |
Feb 23, 2021 |
4 AOPs
|
| 210 |
191: Neuronal dysfunction |
188: Neuroinflammation |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 212 |
193: Decreased, Nitric Oxide |
166: Decreased, Long-term potentiation (LTP) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 213 |
195: Inhibition, NMDARs |
52: Decreased, Calcium influx |
Nov 29, 2016 |
Apr 7, 2018 |
2 AOPs
|
| 214 |
195: Inhibition, NMDARs |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 215 |
195: Inhibition, NMDARs |
191: Neuronal dysfunction |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 228 |
201: Binding of antagonist, NMDA receptors |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 128 |
111: Agonism, Estrogen receptor |
307: Increase, Vitellogenin synthesis in liver |
Nov 29, 2016 |
Jun 24, 2024 |
3 AOPs
|
| 93 |
77: Production, Critical Metabolites (CGA 330050 and CGA 265307) |
164: Induction, Liver “Dysfunctional” Changes by CGA 330050 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 94 |
78: Reduction, Cumulative fecundity and spawning |
360: Decrease, Population growth rate |
Nov 29, 2016 |
Mar 20, 2017 |
12 AOPs
|
| 95 |
79: Inhibition, Cyclooxygenase activity |
243: Reduction, Prostaglandin E2 concentration |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 96 |
80: Up Regulation, CYP1A1 |
209: Peptide Oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 104 |
84: Up Regulation, CYP1B1 |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 108 |
87: Release, Cytokine |
149: Increase, Inflammation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 110 |
89: Synthesis, De Novo Fatty Acid (FA) |
291: Accumulation, Triglyceride |
Nov 29, 2016 |
Mar 29, 2024 |
2 AOPs
|
| 116 |
103: Increase, EcR hyperactivation |
60: Induction, Chitin degradation and resorption |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 123 |
106: Reduction, Eggshell thickness |
253: N/A, Reproductive failure |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|